OLE Therapy With BE Patients in Home Care Study (NCT06926881)
Oscillating Lung Expansion (OLE) Therapy in the Bronchiectasis Patients (BE) Home Care Study Protocol
π©Ί Plain-English Summary (8th-Grade Level)
The study will examine how the performance of Oscillating Lung Expansion (OLE) therapy affects the respiratory health of patients with Bronchiectasis (BE). The patient will use the BiWaze Clear system for their airway clearance therapy, instead of their previously prescribed therapy. BiWaze Clear is an FDA-cleared respiratory therapy for assisting patients in loosening and mobilizing secretions as well as treating and preventing atelectasis by providing lung expansion and high-frequency oscillation therapies, combined with aerosol delivery. The patient will perform airway clearance with BiWaze Clear as prescribed. The system uses a disposable breathing circuit, which is a single patient use, disposable circuit. The treatment duration is 6 months . The BiWaze Clear System is indicated for the mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis and has the ability to provide supplemental oxygen when used with an oxygen supply.
Who can join: Review the eligibility criteria below.
Location: Yale School of Medicine β New Haven, Connecticut
Age range: 5 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (5 Sites)
- Yale School of Medicine β New Haven, Connecticut
- Central Florida Pulmonary Group, P.A. β Orlando, Florida
- Treasure Coast Medical Research Group, LLC β Port Saint Lucie, Florida
- Metropolitan Clinical Research β Tamarac, Florida
- University of South Florida -Tampa General Hospital β Tampa, Florida
π Contact the Study Coordinator
Phone: (952) 200-6228
Email: tdahl@delvehealth.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Bronchiectasis
- Clairleafα΅α΄Ή: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine β Newport Beach, California
- Simeox 200 US Study β Charleston, South Carolina
- The AIRTIVITYβ’ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis β Birmingham, Alabama
- Itraconazole Therapy In Bronchiectasis With Airway Mold β Rochester, Minnesota
- Hypertonic Saline in NCFB β Chapel Hill, North Carolina
Explore by condition: All Bronchiectasis clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.